Royalty Pharma
RPRX
#623
Rank
A$59.18 B
Marketcap
A$102.94
Share price
-0.01%
Change (1 day)
69.80%
Change (1 year)

Royalty Pharma (RPRX) - Total debt

Total debt on the balance sheet as of June 2026 : A$13.43 Billion

According to Royalty Pharma's latest financial reports the company's total debt is A$13.43 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Royalty Pharma - Total debt on balance sheet (from 2019 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$13.36 B9.19%
2024-12-31A$12.23 B35.91%
2023-12-31A$9.00 B-13.89%
2022-12-31A$10.45 B6.84%
2021-12-31A$9.78 B29.39%
2020-12-31A$7.56 B-15.1%
2019-12-31A$8.90 B-3.72%
2018-12-31A$9.25 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Abbott Laboratories
ABT
A$51.03 B 279.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$74.20 B 452.37%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$0.91 B-93.19%๐Ÿ‡บ๐Ÿ‡ธ USA